Title:
FGFR4 KINASE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/182062
Kind Code:
A1
Abstract:
The present invention relates to an FGFR4 kinase inhibitor, a preparation method therefor and use thereof. The present invention relates to a compound of formula I, or a pharmaceutically acceptable salt, solvate, polymorph or isomer thereof, and use thereof in the preparation of a drug for the treatment of FGFR4-mediated diseases.
Inventors:
WANG JINGHAN (CN)
YAO JINSUO (CN)
DUAN XIAOWEI (CN)
YUAN BAOKUN (CN)
LIU XIJIE (CN)
JIAO NAN (CN)
MIN WANGYANG (CN)
SUN YING (CN)
LU CHANG (CN)
SUN YINGHUI (CN)
ZHANG JIUQING (CN)
JI YELING (CN)
HOU DENG (CN)
YAO JINSUO (CN)
DUAN XIAOWEI (CN)
YUAN BAOKUN (CN)
LIU XIJIE (CN)
JIAO NAN (CN)
MIN WANGYANG (CN)
SUN YING (CN)
LU CHANG (CN)
SUN YINGHUI (CN)
ZHANG JIUQING (CN)
JI YELING (CN)
HOU DENG (CN)
Application Number:
PCT/CN2020/078098
Publication Date:
September 17, 2020
Filing Date:
March 06, 2020
Export Citation:
Assignee:
SHOUYAO HOLDINGS BEIJING CO LTD (CN)
International Classes:
C07D519/00; A61K31/4375; A61K31/438; A61K31/496; A61K31/499; A61K31/4995; A61K31/5377; A61K31/5386; A61K31/541; A61P35/00; C07D471/14
Domestic Patent References:
| WO2018004258A1 | 2018-01-04 |
Foreign References:
| CN1646529A | 2005-07-27 |
Other References:
See also references of EP 3936509A4
Attorney, Agent or Firm:
CN-KNOWHOW INTELLECTUAL PROPERTY AGENT LIMITED (CN)
Download PDF: